<DOC>
	<DOCNO>NCT01008891</DOCNO>
	<brief_summary>Study Objective : To demonstrate equivalent clinical radiologic outcomes `` gold standard '' ( ABG ) representative clinical model ( foot ankle fusion ) Study Hypothesis : Augment™ Injectable equivalent bone graft substitute autologous bone graft application show superiority analysis safety non-inferiority analysis effectiveness Study Rationale : Evaluate fully synthetic bone graft material facilitate fusion condition injury require bone graft representative clinical fusion model thus opportunity provide equivalent union rate ABG without necessitate additional invasive procedure harvest graft</brief_summary>
	<brief_title>Augment™ Injectable Bone Graft Compared Autologous Bone Graft Foot Ankle Fusions</brief_title>
	<detailed_description>Musculoskeletal problem pervasive throughout population age group sex . Half Americans need service fracture point lifetime accord widely publish article present 2003 annual meet American Academy Orthopedic Surgeons ( AAOS ) . Many musculoskeletal problem , fracture non-unions require bone graft ensure adequate bone healing . One widely use option bone graft autologous bone however ; clinical difficulty associate ABG ( autologous bone graft ) . Most difficulty result harvest bone graft , include increase operative time , hospital stay cost , increase blood loss , post-operative pain , risk infection and/or fracture . The morbidity associate ABG limit amount available harvest directed surgeon look well alternative chemotactic , mitogenic , angiogenic bone graft substitute alternative fracture augmentation accelerate healing ( St. John et al , 2003 ) . Currently , generally accept alternative ABG fusion procedure foot ankle . In order demonstrate product 's effectiveness , necessary show equivalence autogenous bone graft term safety effectiveness . The purpose study examine safety efficacy Augment™ Injectable Bone Graft ( Beta-TCP/ Bovine Collagen matrix + rhPDGF-BB ) facilitate equivalent mean time union ABG foot ankle fusion model . Our hypothesis intraoperative application Augment™ Injectable Bone Graft ( Augment™ Injectable ) foot ankle fusion procedure demonstrate least equivalent efficacy gold standard autogenous bone graft avoid trauma sequela associate additional surgical procedure .</detailed_description>
	<criteria>Bone defect hindfoot ankle require fusion supplemental bone graft/substitute , require one follow procedure : Ankle joint fusion Subtalar fusion Calcaneocuboid fusion Talonavicular fusion Triple arthrodesis ( subtalar , talonavicular calcaneocuboid joint ) Double fusion ( combination two following : subtalar , talonavicular calcaneocuboid joint ) Previous fusion surgery propose site Patient use chronic medication know affect skeleton ( e.g. , glucocorticoid usage &gt; 10mg/day ) Pregnant female intend become pregnant study period Morbidly obese ( BMI &gt; 45 kg/m2 ) Currently untreated malignant neoplasm ( ) , currently undergo radio chemotherapy diagnose hypercalcemia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>arthritis</keyword>
	<keyword>ankle pain</keyword>
	<keyword>foot pain</keyword>
	<keyword>hindfoot fracture</keyword>
	<keyword>ankle fracture</keyword>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>arthrosis</keyword>
	<keyword>Foot/Hindfoot Fusion</keyword>
</DOC>